46,000 Shares of Aveanna Healthcare Holdings Inc. $AVAH Bought by Oakmont Investment Advisors Inc.

Oakmont Investment Advisors Inc. bought a new stake in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 46,000 shares of the company’s stock, valued at approximately $571,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in AVAH. Farther Finance Advisors LLC boosted its stake in shares of Aveanna Healthcare by 217.1% during the 3rd quarter. Farther Finance Advisors LLC now owns 2,978 shares of the company’s stock worth $37,000 after purchasing an additional 2,039 shares during the last quarter. Caitong International Asset Management Co. Ltd grew its holdings in shares of Aveanna Healthcare by 252.4% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after buying an additional 2,400 shares in the last quarter. Diversified Trust Co grew its holdings in shares of Aveanna Healthcare by 14.9% during the first quarter. Diversified Trust Co now owns 22,293 shares of the company’s stock worth $144,000 after buying an additional 2,893 shares in the last quarter. EverSource Wealth Advisors LLC raised its position in shares of Aveanna Healthcare by 22.1% in the first quarter. EverSource Wealth Advisors LLC now owns 17,552 shares of the company’s stock valued at $113,000 after buying an additional 3,172 shares during the last quarter. Finally, Nisa Investment Advisors LLC raised its position in shares of Aveanna Healthcare by 104.7% in the third quarter. Nisa Investment Advisors LLC now owns 11,181 shares of the company’s stock valued at $139,000 after buying an additional 5,720 shares during the last quarter. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts recently issued reports on AVAH shares. JPMorgan Chase & Co. upped their price objective on shares of Aveanna Healthcare from $8.00 to $15.00 and gave the company a “neutral” rating in a research note on Monday, September 14th. BMO Capital Markets lifted their target price on shares of Aveanna Healthcare from $10.00 to $14.00 and gave the stock an “outperform” rating in a research note on Friday, August 14th. Royal Bank Of Canada boosted their price target on Aveanna Healthcare from $10.00 to $16.00 and gave the company an “outperform” rating in a report on Monday, August 24th. Wall Street Zen downgraded Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 15th. Finally, Barclays increased their price target on Aveanna Healthcare from $9.50 to $15.00 and gave the stock an “overweight” rating in a research note on Friday, August 28th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, Aveanna Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $14.06.

Insider Buying and Selling at Aveanna Healthcare

In related news, major shareholder Robert Williams, Jr. sold 14,500,002 shares of the firm’s stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $11.50, for a total value of $166,750,023.00. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, major shareholder Paul Vigano sold 14,500,002 shares of the firm’s stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $11.50, for a total transaction of $166,750,023.00. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 48,566,081 shares of company stock worth $558,509,932. 5.30% of the stock is currently owned by insiders.

Aveanna Healthcare Stock Performance

NASDAQ AVAH opened at $12.99 on Thursday. The business’s 50-day moving average price is $13.04 and its 200 day moving average price is $9.71. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 4.47. Aveanna Healthcare Holdings Inc. has a twelve month low of $5.93 and a twelve month high of $14.71. The company has a market capitalization of $2.83 billion, a PE ratio of 10.56, a price-to-earnings-growth ratio of 0.78 and a beta of 1.95.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings results on Thursday, August 13th. The company reported $0.22 EPS for the quarter, beating the consensus estimate of $0.17 by $0.05. Aveanna Healthcare had a return on equity of 80.70% and a net margin of 10.56%. The company had revenue of $670.48 million during the quarter, compared to analysts’ expectations of $638.61 million. On average, research analysts predict that Aveanna Healthcare Holdings Inc. will post 0.77 earnings per share for the current year.

Aveanna Healthcare Profile

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) is a provider of home-based healthcare services in the United States. The company serves patients across the lifespan, with a particular focus on children and adults who require ongoing medical support, skilled nursing or assistance with daily activities.

Aveanna’s services include private-duty nursing, home health care, hospice and palliative care, therapy, medical solutions and personal-care services. Its clinicians and caregivers support patients with complex medical conditions, disabilities and other needs in their homes and community settings, working with patients, families, physicians and healthcare organizations.

The company was established in 2016 through the combination of Pediatric Services of America and Epic Health Services and became a publicly traded company in 2021.